Profile
Michael Leviten worked as a Director-Molecular Biology at Bayhill Therapeutics, Inc. from 2005 to 2013.
He also worked as a Senior Scientist at Deltagen, Inc. Dr. Leviten received his undergraduate degree from Harvard University and his doctorate degree from the University of California San Diego.
Former positions of Michael Leviten
| Companies | Position | End |
|---|---|---|
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 25/12/2013 |
| DELTAGEN INC. | Chief Tech/Sci/R&D Officer | - |
Training of Michael Leviten
| Harvard University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Michael Leviten
